Article
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
Journal of hepatology - 1 Apr 2014
Nkongolo Shirin, Ni Yi, Lempp Florian A, Kaufman Christina, Lindner Thomas, Esser-Nobis Katharina, Lohmann Volker, Mier Walter, Mehrle Stefan, Urban Stephan
Abstract excerpt
BACKGROUND & AIMS: Chronic hepatitis B and hepatitis D are global health problems caused by the human hepatitis B and hepatitis D virus. The myristoylated preS1 domain of the large envelope protein mediates specific binding to hepatocytes by sodium taurocholate co-transporting polypeptide (NTCP). NTCP is a bile salt transporter known to be inhibited by cyclosporin A. This study aimed to characterize the effect of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
